# Study of ADXS11-001 in Participants With High Risk Locally Advanced Cervical Cancer

> **NCT02853604** · PHASE3 · TERMINATED · sponsor: **Advaxis, Inc.** · enrollment: 110 (actual)

## Conditions studied

- High Risk Cervical Cancer
- Advanced Cervical Cancer

## Interventions

- **DRUG:** ADXS11-001
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02853604
- **Lead sponsor:** Advaxis, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-12-15
- **Primary completion:** 2019-07-31
- **Final completion:** 2019-07-31
- **Target enrollment:** 110 (ACTUAL)
- **Last updated:** 2023-03-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02853604

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02853604, "Study of ADXS11-001 in Participants With High Risk Locally Advanced Cervical Cancer". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02853604. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*